Download FREE Report Sample
Download Free sampleCholinesterase inhibitors (also called acetylcholinesterase inhibitors) are a group of medicines that block the normal breakdown of acetylcholine. Acetylcholine is the main neurotransmitter found in the body and has functions in both the peripheral nervous system and the central nervous system. For example, acetylcholine is released by motor neurons to activate muscles; acetylcholine also has an important role in arousal, attention, learning, memory and motivation.
Cholinesterase inhibitors block the action of the enzyme cholinesterase, which is responsible for breaking down acetylcholine. This increases levels of acetylcholine in the synaptic cleft (the space between two nerve endings).
The main use of cholinesterase inhibitors is for the treatment of dementia in patients with Alzheimer's disease. People with Alzheimer's disease have reduced levels of acetylcholine in the brain. Cholinesterase inhibitors have been shown to have a modest effect on dementia symptoms such as cognition.
Cholinesterase Inhibitors Market contains market size and forecasts of Cholinesterase Inhibitors in global, including the following market information:
Global Cholinesterase Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cholinesterase Inhibitors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cholinesterase Inhibitors companies in 2021 (%)
The global Cholinesterase Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Haboyin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cholinesterase Inhibitors include Pfizer, Shionogi Pharma, Daiichi Pharmaceutical Co Ltd, Novartis, F. Hoffmann-La Roche, Merck, Eli Lily & Co, Taloph pharmaceutical and Forward group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cholinesterase Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cholinesterase Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cholinesterase Inhibitors Market Segment Percentages, by Type, 2021 (%)
Global Cholinesterase Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cholinesterase Inhibitors Market Segment Percentages, by Application, 2021 (%)
Global Cholinesterase Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cholinesterase Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy